558 related articles for article (PubMed ID: 33203470)
21. The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling.
Zhang C; Xiang T; Li S; Ye L; Feng Y; Pei L; Li L; Wang X; Sun R; Ren G; Tao Q
Cell Death Dis; 2018 May; 9(5):573. PubMed ID: 29760376
[TBL] [Abstract][Full Text] [Related]
22. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
23. FAM96A and FAM96B function as new tumor suppressor genes in breast cancer through regulation of the Wnt/β-catenin signaling pathway.
Zhang DD; Sun XL; Liang ZY; Wang XY; Zhang LN
Life Sci; 2022 Nov; 308():120983. PubMed ID: 36165859
[TBL] [Abstract][Full Text] [Related]
24. ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathway.
Chen L; Wu X; Xie H; Yao N; Xia Y; Ma G; Qian M; Ge H; Cui Y; Huang Y; Wang S; Zheng M
Cell Death Dis; 2019 Feb; 10(3):169. PubMed ID: 30787268
[TBL] [Abstract][Full Text] [Related]
25. Suppression of N-Glycosylation of Zinc Finger Protein 471 Affects Proliferation, Invasion, and Docetaxel Sensitivity of Tongue Squamous Cell Carcinoma via Regulation of c-Myc.
Liu Y; Cai X; Hu S; Wang Z; Tian H; Wang H
Am J Pathol; 2024 Jun; 194(6):1106-1125. PubMed ID: 38749608
[TBL] [Abstract][Full Text] [Related]
26. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
27. Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation.
Yue Y; Yuan Y; Li L; Fan J; Li C; Peng W; Ren G
Int J Mol Med; 2018 May; 41(5):2986-2996. PubMed ID: 29436596
[TBL] [Abstract][Full Text] [Related]
28. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
Yan D; Avtanski D; Saxena NK; Sharma D
J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
[TBL] [Abstract][Full Text] [Related]
29. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
[TBL] [Abstract][Full Text] [Related]
30. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
32. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Zhang J; Lu J; Chen Y; Li H; Lin L
J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
[No Abstract] [Full Text] [Related]
33. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.
Li J; Zhang M; He T; Li H; Cao T; Zheng L; Guo M
Sci Rep; 2017 Jun; 7(1):3325. PubMed ID: 28607412
[TBL] [Abstract][Full Text] [Related]
34. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Transl Med; 2018 Jan; 16(1):7. PubMed ID: 29343267
[TBL] [Abstract][Full Text] [Related]
35. Secreted Frizzled Related Protein 2 Modulates Epithelial-Mesenchymal Transition and Stemness via Wnt/β-Catenin Signaling in Choriocarcinoma.
Zeng X; Zhang Y; Xu H; Zhang T; Xue Y; An R
Cell Physiol Biochem; 2018; 50(5):1815-1831. PubMed ID: 30396168
[TBL] [Abstract][Full Text] [Related]
36. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
[TBL] [Abstract][Full Text] [Related]
37. Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling.
Zhang J; Liu Y; Pu S; He J; Zhou C
Breast Cancer Res Treat; 2021 Feb; 186(1):247-258. PubMed ID: 33423159
[TBL] [Abstract][Full Text] [Related]
38. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.
Li L; Xu J; Qiu G; Ying J; Du Z; Xiang T; Wong KY; Srivastava G; Zhu XF; Mok TS; Chan AT; Chan FK; Ambinder RF; Tao Q
Theranostics; 2018; 8(1):61-77. PubMed ID: 29290793
[No Abstract] [Full Text] [Related]
39. Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer.
Xiao Y; Xiang T; Luo X; Li C; Li Q; Peng W; Li L; Li S; Wang Z; Tang L; Ren G; Tao Q
PLoS One; 2014; 9(10):e110990. PubMed ID: 25360542
[TBL] [Abstract][Full Text] [Related]
40. BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27.
He J; Wu M; Xiong L; Gong Y; Yu R; Peng W; Li L; Li L; Tian S; Wang Y; Tao Q; Xiang T
Clin Epigenetics; 2020 Jun; 12(1):82. PubMed ID: 32517789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
